However, study also indicated that wild-type oncolytic viruses may be effective against nasopharyngeal carcinoma by directly activating the helper CD4+ T cell response, possibly because different virus types have different changes in peripheral blood T lymphocyte subsets (19). Here, CD4 is linked to nasopharyngeal carcinoma.